RSS   Newsletter   Contact   Advertise with us

U.S. urges India to lift export ban on pharmaceutical ingredients

Share on Twitter Share on LinkedIn
Christian Fernsby ▼ | March 31, 2020
Officials of the U.S. have asked India to lift the ban imposed on export of pharmaceutical ingredients amid the coronavirus pandemic.
Pharmaceutical ingredients
India   Pharmaceutical ingredients
The move comes due to the rise in demand in the U.S., now the most-affected country with nearly 164,500 confirmed cases and 3,100 deaths to date.

Topics: U.S. India export ban pharmaceutical

Currently, the U.S. now has more confirmed coronavirus cases than any other country, surpassing China and Italy.

India and U.S. governments are in discussions on lightening restrictions on pharmaceutical ingredients exports from India, reported news agency ANI.

India is one of the largest suppliers of generics and pharmaceutical ingredients.

The export ban in India has been put in place to ensure an adequate supply of medicines during the outbreak in the country, which reported 1,251 Covid-19 cases and 32 deaths so far.